Arcturus Therapeutics to Showcase mRNA Technologies at Upcoming Investor Conferences

jueves, 28 de agosto de 2025, 4:40 am ET1 min de lectura
ARCT--

Arcturus Therapeutics (ARCT) will participate in four investor conferences in September 2025 to showcase its mRNA technologies and extensive pipeline targeting liver and respiratory diseases. The company has a global presence with partnerships and a robust patent portfolio. Arcturus' CEO and executives will engage with investors at Citi's Biopharma Back to School Conference, Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and H.C. Wainwright Global Investment Conference.

Arcturus Therapeutics to Showcase mRNA Technologies at Upcoming Investor Conferences

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios